Impact of scaling up SARS-CoV-2 vaccination on COVID-19 hospitalizations in Spain
Background: The advent of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines has been associated with a significant decline in coronavirus disease 2019 (COVID-19) hospitalizations and deaths. However, little is known about the benefits experienced by different population groups an...
Enregistré dans:
Auteurs principaux: | Ignacio Barandalla, Carmen Alvarez, Pablo Barreiro, Carmen de Mendoza, Rubén González-Crespo, Vicente Soriano |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Elsevier
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/d2260ed96fe94073a6f58d39e72cc77c |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Vaccinated Patients Admitted in ICU with Severe Pneumonia Due to SARS-CoV-2: A Multicenter Pilot Study
par: Ángel Estella, et autres
Publié: (2021) -
Development of an Inactivated Vaccine against SARS CoV-2
par: Shaikh Terkis Islam Pavel, et autres
Publié: (2021) -
Rotavirus gastroenteritis hospitalizations in provinces with different vaccination coverage rates in Spain, 2013–2018
par: J. Ruiz-Contreras, et autres
Publié: (2021) -
Sweet Syndrome Following SARS-CoV2 Vaccination
par: Maria Efenesia Baffa, et autres
Publié: (2021) -
Cutaneous Adverse Reactions Associated with SARS-CoV-2 Vaccines
par: Francesco Bellinato, et autres
Publié: (2021)